Simon Cork
Dr. Simon Cork is a researcher at Anglia Ruskin University with expertise in obesity and metabolic health. His insights into the long-term effectiveness of weight loss medications, particularly tirzepatide, highlight the importance of understanding weight management therapies in relation to rising healthcare costs associated with obesity-related conditions.
Not in the pool (under ¢1).
Recent news mentions
Simon Cork highlights the unknown effects of weight-loss drugs used purely for cosmetic purposes.
They have six packs - but they're still jumping on and off weight-loss jabs
United Kingdom· 2025-11-30
Dr Simon Cork, a senior lecturer in physiology, commented on the preliminary results of the weight-loss pill.
Daily pill helps patients lose 12% of body weight in early trial | Diets and dietingUnited Kingdom· 2025-08-07
Simon Cork is a lecturer at Anglia Ruskin University studying obesity.
Η νέα γενιά φαρμάκων απώλειας βάρους είναι πιο αποτελεσματική
Greece· 2025-07-11
Simon Cork is a professor at Anglia Ruskin University who has studied obesity.
Nuevos datos muestran cuán potentes pueden ser los próximos fármacos para la pérdida de peso
Guatemala· 2025-06-28
Dr Simon Cork, of Anglia Ruskin University, noted the long-term effectiveness of tirzepatide in maintaining weight loss.
People using drug Mounjaro sustain weight loss over three years, trial finds | ObesityUnited Kingdom· 2025-04-11
